About
Bone Targeted Therapeutics & Diagnostics
Areas of Focus
Categories
San Diego & Southern California
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
801
By Phase
PHASE2: 6PHASE1/PHASE2: 1PHASE3: 1
By Status
COMPLETED: 4RECRUITING: 2TERMINATED: 2
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06847191Lead Sponsor
NE3107 in Adults With Neurological Symptoms of Long COVID
PHASE2Recruiting
208 participants
Started: Apr 29, 2025 · Completed: Jan 31, 2026
NCT06757010Lead Sponsor
A Study of NE3107 in Early Parkinson's
PHASE2Recruiting
60 participants
Started: Mar 26, 2025 · Completed: Jan 2, 2026
NCT05970575Collaborator
Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury
PHASE2Terminated
4 participants
Started: Dec 21, 2023 · Completed: Jul 21, 2025
NCT05227820Collaborator
Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia
PHASE2Completed
23 participants
Started: Jan 19, 2022 · Completed: Aug 20, 2022
NCT05083260Lead Sponsor
NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
PHASE1/PHASE2Completed
46 participants
Started: Jan 4, 2022 · Completed: Jan 4, 2023
Locations (1)
Headquarters
Pasadena, CA, United States
Map
Loading map...